Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1218 Articles

Jon C. Ogg | Oct 19, 2019 at 6:45 AM EDT

How Biotech and Big Pharma Have Upside Heading Into Earnings

Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.

Jon C. Ogg | Oct 16, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, Alibaba, Amazon, AT&T, Comcast, Delphi, DocuSign, J&J, JPMorgan, T-Mobile, Verizon, Wells Fargo and More

Wednesday's top analyst upgrades, downgrades and initiations included Adobe, Alibaba, Amazon.com, AT&T, Comcast, Delphi Technologies, DocuSign, Johnson & Johnson, JPMorgan,…

Chris Lange | Oct 15, 2019 at 10:29 AM EDT

Johnson & Johnson Offers a Strong Start to Earnings Season

Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.

Chris Lange | Oct 14, 2019 at 12:10 PM EDT

What to Expect When Johnson & Johnson Reports Tuesday

Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday, and analysts'…

Chris Lange | Oct 13, 2019 at 6:50 AM EDT

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.

Jon C. Ogg | Oct 11, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto,…

Chris Lange | Oct 9, 2019 at 12:25 PM EDT

Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling

Johnson & Johnson shares dropped on Wednesday following the announcement that a jury has awarded $8 billion in damages to…

Chris Lange | Oct 2, 2019 at 10:50 AM EDT

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with…

Paul Ausick | Oct 1, 2019 at 12:00 PM EDT

Unusual Settlement Deal Proposed for Opioid Lawsuits

Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy…

Lee Jackson | Sep 30, 2019 at 7:30 AM EDT

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

The last thing investors want is a value trap loser that stays stagnant, but all these top companies have solid…

Jon C. Ogg | Sep 13, 2019 at 7:11 AM EDT

As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus

As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked…

Jon C. Ogg | Aug 27, 2019 at 11:25 AM EDT

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Jon C. Ogg | Jul 18, 2019 at 7:20 AM EDT

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to…

Jon C. Ogg | Jul 17, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola,…

1 … 28 29 30 31 32 … 82

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Adobe, Alibaba, Amazon, AT&T, Comcast, Delphi, DocuSign, J&J, JPMorgan, T-Mobile, Verizon, Wells Fargo and More

Johnson & Johnson Offers a Strong Start to Earnings Season

What to Expect When Johnson & Johnson Reports Tuesday

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

Unusual Settlement Deal Proposed for Opioid Lawsuits

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

How Biotech and Big Pharma Have Upside Heading Into Earnings

Top Analyst Upgrades and Downgrades: Adobe, Alibaba, Amazon, AT&T, Comcast, Delphi, DocuSign, J&J, JPMorgan, T-Mobile, Verizon, Wells Fargo and More

Johnson & Johnson Offers a Strong Start to Earnings Season

What to Expect When Johnson & Johnson Reports Tuesday

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Johnson & Johnson Has a Lot on Its Hands After $8 Billion Court Ruling

Johnson & Johnson May Have Just Dodged a Big Opioid Bullet

Unusual Settlement Deal Proposed for Opioid Lawsuits

5 Dow Jones Industrial Average 2019 Laggards Could Be Big Q4 Winners

As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus

Opioid Verdict: A Possible Victory for Johnson & Johnson and Loss for Everyone Else?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray, VMware and More

Social Security’s Timetable for Collapse Just Moved Up – and That’s Not Even the Worst News

“He’s a Wolf in the Middle of the Sheep Pen”: Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants

Here’s How You Can Retire to St. Petersburg, Florida, at 65 on $925,000 Where the Sun Shines

Featured Reads

Social Security's Timetable for Collapse Just Moved Up - and That's Not Even the Worst News

"He's a Wolf in the Middle of the Sheep Pen": Dave Ramsey to a Church Elder Watching a Fellow Member Sell Whole Life Insurance to Congregants